Levosimendan in Sepsis
Copyright policy )Levosimendan in Sepsis
Comment on : Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D. Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. N Engl J Med. 2016 Oct 27;375(17):1638-1648. doi: 10.1056/NEJMoa1609409. Epub 2016 Oct 5. PMID: 27705084.
- Assistance Publique -Hopitaux De Paris France
- Roma Tre University Italy
- Justus Liebig University Giessen Germany
- Imperial College London United Kingdom
- University of Lübeck Germany
Pyridazines, Cardiotonic Agents, cardiotonic agents; humans; sepsis; hydrazones; pyridazines; medicine (all), Cardiotonic Agents / therapeutic use, General & Internal Medicine, Sepsis, Hydrazones, Humans, 11 Medical And Health Sciences, Sepsis / drug therapy
Pyridazines, Cardiotonic Agents, cardiotonic agents; humans; sepsis; hydrazones; pyridazines; medicine (all), Cardiotonic Agents / therapeutic use, General & Internal Medicine, Sepsis, Hydrazones, Humans, 11 Medical And Health Sciences, Sepsis / drug therapy
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).11 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!